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Abstract 
Objective: Due to the high incidence of bacterial vaginosis (BV) 
and its resistance to chemical medications and considering the 
anti-bacterial and anti-fungal effects of Myrtus communis, the 
present study aimed to compare the therapeutic effects of the 
vaginal gel of M. communis 2% (in metronidazole base) with 
metronidazole vaginal gel 0.75% alone on BV. 
Materials and Methods: This research was a randomized 
controlled clinical trial conducted on 80 women of 18-40 years old 
with BV. Patients were divided into two groups of 40 women. 
Diagnostic criteria were Amsel's criteria and Gram staining. The 
first group received vaginal gel of metronidazole plus M. 
communis 2% and the second group received metronidazole 
vaginal gel alone for five consecutive nights. Therapeutic effects 
and Amsel’s criteria were assessed after one week. Finally, the 
data were analyzed by SPSS 16 using t-test and Chi square tests. 
Results: There was a significant difference in the therapeutic 
response between the two groups. The results demonstrated that 
the combination of metronidazole and M. communis had a higher 
efficiency (p<0.05). The patients receiving M. communis in 
metronidazole gel base did not experience any recurrent BV, but 
30% of patients taking metronidazole alone faced recurrent BV 
after three weeks of follow up. 
Conclusion: Findings of the study suggested that adding M. 
communis extract to metronidazole increases the efficiency of BV 
treatment. 
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Introduction 
Bacterial vaginosis (BV) which is the 
most prevalent form of vaginitis among 
women of reproductive age, is a revolution 
in bacterial flora of the vagina that leads to 
a decrease in native vaginal bacteria and 
overgrowth of anaerobic bacteria 
(Danforth and Gibbs, 2008). Since 
vaginitis causes problems for women, they 
seek for treatment (Farage et al., 2008). 
The most common infectious types of 
vaginitis are bacterial vaginosis, 
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candidiasis, and trichomoniasis 
(Mashburn, 2012). The etiology of BV is 
not entirely known; however, researchers 
believe that BV is defined by a loss of the 
native lactobacilli producing hydrogen 
peroxide, and an overgrowth of anaerobic 
bacteria such as Gardenela vaginalis, 
bactrioid species, mobiluncus species and 
Mycoplasma (Danforth and Gibbs, 2008 
;Novak and Berek, 2007; Reichman et al., 
2009; Allsworth, 2010). Vaginal 
lactobacilli acidify normal vagina 
environment, and inhibit the overgrowth of 
other vaginal bacteria, especially anaerobic 
bacteria (Ness et al., 2004; Riggs et al., 
2007).  
Bacterial vaginosis has been related to 
various serious complications such as 
endometritis, pelvic inﬂammatory disease 
(PID), Neisseria gonorrhoeae and 
Chlamydia trachomatis infections, preterm 
delivery, chorioamnionitis, infections after 
gynecologic surgeries, spontaneous 
abortion, etc. (Danforth and Gibbs, 2008, 
Reichman et al. 2009, Klebanoff et al., 
2010). Having multiple sex partners, 
inappropriate condom usage, smoking, and 
intrauterine contraceptive devices (IUDs) 
are the most important causes of BV 
(Farage et al., 2008; Schwebke et al., 
2004; Koumans et al., 2007; Seyyedi F et 
al., 2016). Inversely, oral contraceptive 
pills prevent bacterial vaginosis (Klebanoff 
et al., 2010). 
The most frequent symptom of BV is 
unpleasant vaginal discharge odor 
(Danforth and Gibbs, 2008, Klebanoff et 
al., 2010), which has negative outcomes on 
sexual and individual life of women (Leite 
et al., 2010). The clinical symptoms of BV 
include thin, grey-white, homogeneous and 
fishy-smelling discharge (Schwebke et al., 
2004, Donders et al., 2014). 
The major treatment of bacterial 
vaginosis is the usage of antibiotics (local 
or systemical). Antiseptics or probiotics 
can be also applied in treatment of BV. 
Metronidazole and clindamycin are two 
major antibiotics approved for treatment of 
BV. Furthermore, acidifying the vagina by 
acids such as lactic acid may enhance 
colonization of lactobacilli and prevent 
overgrowth of anaerobic microorganisms 
(Verstraelen et al., 2009; Löfmark et al., 
2010). 
Metronidazole has been successfully 
used for the treatment of anaerobic 
infections, septicemia, endocarditis, 
gynecologic infections, intra-abdominal 
infections, for more than 45 years (Brandt 
et al., 2008). Metronidazole  is  the  key 
standard  medication  in  treatment  of  BV  
with  an  effective activity against  
anaerobic bacteria and a low activity 
against lactobacilli. Metronidazole has 
considerable side effects as well. This 
antibiotic is metabolized in the liver. 
The concomitant use of metronidazole 
and anticoagulants such as warfarin causes 
prolongation of the prothrombin time. The 
most common complication of 
metronidazole is gastrointestinal problems 
including nausea, vomiting, metallic taste 
in the mouth and diarrhea. Furthermore, 
metronidazole causes other complications 
including drowsiness, dark-colored urine, 
dizziness, allergy, reduced transient 
neutropenia, candida infection, pancreatic 
inflammation, etc. Its infrequent serious 
complications such as peripheral 
neuropathy and convulsive seizures, 
described mainly by numbness or 
extremity paresthesia have been reported 
in patients taking prolonged metronidazole 
treatment (Brandt et al., 2008; Rafiean-
Kopaei et al., 2012). 
In recent years, the general population 
show a considerable tendency toward 
traditional treatments and medicinal herbs. 
Various research have evaluated 
antibacterial (Amirmohammadi et al., 
2014; Sharafati-Chaleshtori and Rafieian-
kopaei, 2014), antiparasitic (Shirzad et al., 
2011; Bahmani and Rafieian-Kopaei, 2014) 
and anticancer (Ghassemi Dehkordi et al., 
2003) effects of the medical plants. One of 
these herbs is Myrtus communis and 
numerous studies have reported its 
therapeutic properties 
M. communis L, also known as Myrtus 
or Myrtle, belongs to the Myrtaceae 
family. This plant is an odorant, evergreen, 
Efficacy of metronidazole vaginal gel 
AJP, Vol. 7, No. 2, Mar-Apr 2017                                               131 
perennial, erect shrub with maximum 
height of 5 m and a highly branched trunk. 
The young twigs of Myrtus contain 
glandular trichomes, simple, reciprocal and 
sharp leaves with a length of 5 cm. The 
leaves of Myrtus are mainly used in 
medicine. Some important compounds of 
the essential oil of Myrtus leaves are 
terpinyl acetate, geranyl valerate, hexyl 
butyrate and sabinene. Besides, the leaves 
contain tannin, flavonoid and vitamin C, 
without the existence of alkaloid and 
cardiac glycosides (Sobel, 2000).  
Traditional medicine believes that 
Mytrus has astringent, anti-diarrhea and 
antiseptic effects and strengthens hair 
growth. Mytrus was locally used in 
treatment of herpes, nasal mucosa 
inflammation. Extract of this herb can 
inhibit the growth of Staphylococcus 
aureus, Pseudomonas aeruginosa and 
Escherichia coli (Sobel, 2000). 
Given the great prevalence of bacterial 
vaginosis, various side effects of chemical 
medications, resistance of microorganisms  
and due to the attitude of people toward 
herbal medicines , their fewer side effects 
and sometimes their higher efficacy, the 
present study aimed to compare the 
therapeutic effects of the vaginal gel of M. 
communis 2% (in metronidazole base) and 
metronidazole vaginal gel 0.75% alone in 
women with BV referred to Women 
Clinics of Hajar Hospital, affiliated with 
Shahrekord University of Medical 
Sciences, Shahrekord, Iran. 
 
 
Materials and Methods 
This study was a double-blind random-
ized controlled clinical trial. The trial was 
conducted on 80 married women aged 18-
40 years with bacterial vaginosis referred 
to Women Clinics of Hajar Hospital, in 
2014.  
The clinical identification of BV was 
performed by Amsel’s criteria and Gram 
staining. The criteria for patients were 
based on the existence of at least three out 
of the four Amsel’s criteria including 
white or gray homogeneous vaginal 
discharge, discharge pH > 4.5, clue cells 
more than 20 % in the vaginal wet smear, 
and positive “whiff” test (Simbar et al., 
2008). Exclusion criteria were taking 
antibiotics during the past two weeks, 
postmenopausal, virginity and pregnancy, 
hysterectomy, bleeding, pelvic infections, 
women with diseases such as immune 
deficiency and diabetes, presence of sperm 
in smear and allergies to Myrtus. 
Married women aged 18-40 years with 
vaginal discharge who referred to Women 
Clinics of Hajar Hospital, in 2014, were 
studied. After approving the study by the 
Ethics Committee of Shahrekord 
University of Medical Sciences and 
registering in the Iranian Registry of 
Clinical Trials with the IRCT code: 
201411102085N13, the intent women 
were invited to contribute to this study, 
and informed about the aims and method 
of the study. All women signed an 
informed consent. In order to record the 
participants, they were given a 
questionnaire containing demographic 
characteristics, contraceptive method, 
number of pregnancies and medical 
history. Finally, eighty women were 
randomly registered, and randomly 
distributed to two groups of 40 individuals. 
Then, registered women were treated with 
either vaginal gel of M. communis 2% 
(Sobel and Ferris, 2006) (in metronidazole 
base) or metronidazole vaginal gel 0.75% 
alone for five consecutive nights. 
This study was a double blind 
randomized clinical trial (neither statistical 
consultant nor physicians were aware of 
Drug Code). 
The patients were evaluated one week 
after treatment completion for assessing 
therapeutic response. The vaginal 
discharge was cultured on HBT (Human 
Blood Tween) Bilayer Medium. HBT 
medium is a selective and differential 
medium used in the primary separation and 
probabilistic recognition of Gardnerella 
vaginalis from clinical specimens. 
Antibiogram of the isolated bacteria was 
prepared, and antibacterial effects of 
Myrtus extract were assessed in culture. In 
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order to increase the precision of the study, 
the experiments were repeated three times. 
Patients were not allowed to do vaginal 
washing, intercourse and use any vaginal 
medication during treatment. The 
remission and recurrence rates were 
followed 1 and 3 weeks after completion 
of treatment, in both groups. The lack of 
four Amsel's criteria or the presence of 
only one criterion of Amsel was indicator 
of the treatment’s success or failure, 
respectively (Rabiei et al., 2014). If the 
Amsel criteria were not present, it showed 
the success of treatment. If the Amsel 
criteria or criterion including; white or 
gray homogeneous vaginal discharge,  
pH> 4.5, clue cells more than 20 %  in  the 
vaginal wet smear, and positive “whiff” 
test//926), the treatment was unsuccessful. 
Patients who did not show improvement 
seven days after treatment completion 
were excluded and referred for treatment 
with oral metronidazole. 
 
Extraction method 
After collecting the Myrtus leaves from 
Lordegan, confirmation of scientific name, 
and herbarium preparation, the percolation 
extraction method was performed by 
ethanol.  Myrtus extract were added to 
metronidazole (vaginal gel of M. 
communis 2% in metronidazole base). 
Then, two groups of tubes were filled with 
metronidazole vaginal gel alone and 
metronidazole vaginal gel in combination 
with Myrtus. The shapes of tubes were 
identical and were not detectable by the 
physicians and patients. 
 
Determining antioxidant and anti-
microbial activities of Myrtus extract 
The antioxidant activity of Myrtus 
extract was determined by 1-diphenyl-2-
picrylhydrazyl (DPPH) assay (Sobel et al., 
2006). The antimicrobial effects of Myrtus 
extract were estimated by determining its 
minimum inhibitory concentration (MIC). 
First, 20 mg of Myrtus extracts were 
dissolved in 1 ml physiological serum, and 
dilutions of 1.25, 2.5, 5, 10, and 20 mg/ml 
were prepared. Suspension of bacteria 
colonies available in specific medium of 
BHT with turbidity of 0.5 McFarland was 
added to dilutions and incubated at 37°C 
for 2-4 hr. Then, each dilution was 
inoculated into Methylene Blue (EMB) 
Agar medium and incubated at 37°C for 24 
hr. Finally, the cultures were investigated 
based on growth or lack of growth of 
bacteria.  
 
Statistical analysis 
Data were analyzed by SPSS software 
16(Chicago), using frequency, mean, 
standard deviation, the chi-square test and 
independent t-test. 
 
 
Results 
Here, 80 married women with mean age 
of 32.88±6.04 years old and age range of 
19-40 years old participated in this study. 
Each group included 40 married women. 
Most participants in the study had a high 
school education (37.5%), and were 
housekeeper (85.8%). The natural method 
of contraception had higher frequency than 
other methods (34.2 %), and the groups 
were not significantly different (p =.76). 
Also, 90.8% of patients had a history of 
vaginal infection, and 90.5% had received 
previous medical treatment. Moreover, 
27.5% of women had a history of 
household treatment, and only 5% of them 
had a history of hospitalization because of 
infection. Mean of age, age at menarche, 
age at marriage, number of pregnancies, 
number of deliveries and abortions in two 
groups showed no significant difference. 
Besides, education and employment status 
are similar in the two groups (Table 1). 
History of infection, history of infection, 
hospitalization history because of vaginal 
infection, and household treatment of 
infection did not report any significant 
difference between two groups. In 
addition, there was no significant 
difference in clinical symptoms of BV 
before treatment, so the groups had similar 
clinical symptoms (Table 2). Symptoms of 
bacterial vaginosis in both groups after 
treatment were compared (Table 3). 
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Table 1. Demographic characteristics and confounding factor of the participants 
 
 Metronidazole Group 
Mean ± SD 
Metronidazole and Myrtus Group 
Mean ± SD 
p-value  
Age (year) 32.48±6.38 33.40±4.65 0.46 
Age at menarche  (year) 13.45±1.13 13.70±1.74 0.44 
Age of marriage (year) 20.25±4.21 18.85±2.98 0.09 
Number of gestation 2.18±1.31 2.50±1.24 0.26 
Number of delivery 2.05±1.30 2.15±1.09 0.71 
Number of abortions 0.25±0.54 0.35±0.66 0.46 
Employment 
status 
Employed 4 
36 
5 
35 
1 
Unemployed 
Education Illiterate 2 
19 
19 
2 
19 
19 
0.50 
Below diploma 
Diploma and upper 
a
 Data are presented as Mean ± SD. 
 
Table 2. Comparison of symptoms of bacterial vaginosis in both groups before treatment 
symptoms Metronidazole Group 
N               % 
Metronidazole and Myrtus Group 
N             % 
p-value 
Irritation Yes 27             67.5 
13             32.5 
24             60 
16             40 
0.62 
No 
Itching Yes 25             62.5 
15             37.5 
24             60 
16             40 
0.98 
No 
Redness Yes 14             35 
26             65 
12             30 
28             70 
0.81 
No 
Disparonia Yes 16             40 
24             60 
25             62.5 
15             37.5 
0.07 
No 
Fever and Chills Yes 4             10 
36             90 
7             17.5 
33             82.5 
0.51 
No 
Dysuria Yes 14             35 
26             65 
17             42.5 
23             57.5 
0.64 
No 
Dysmenorrhea Yes 18             45 
22             55 
20             50 
20             50 
0.82 
No 
 
Table 3. Comparison of symptoms of bacterial vaginosis in groups after treatment 
P value communis L  Myrtus and Metronidazole Metronidazole symptoms 
percent frequency frequency percent 
o.17 15 6 11 27.5 yes Irritation 
85 34 29 72.5 no 
0.48 30 12 15 37.5 yes Itching 
70 28 25 62.5 no 
0.39 15 6 9 22.5 yes Redness 
85 34 31 77.5 no 
0.40 5 2 4 10 yes Dyspareunia 
95 38 36 90 no 
0.40 10 4 2 5 yes Fever and Chills 
90 36 38 95 no 
0.26 22.5 9 6 15 yes Dysuria 
77.5 31 34 85 no 
0.8 30 12 11 72/5 yes Dysmenorrhea 
70 28 29 72/5 no 
 
 
The two groups indicated no significant 
difference in frequency of remission using 
independent t-test (p <0.001) (Table 4). In 
addition, all patients were treated with 
metronidazole and Myrtus combination 
were satisfied with their remission, and 
examinations did not show reinfection 3 
weeks after treatment completion. 
However, 12 patients (30%) in the 
metronidazole group encountered 
recurring infection. 
 
Table 4. Comparison of recovery rate in groups 
 
Groups Recovery 
Without recovery 
N       % 
With 
recovery 
N        % 
p-value 
Metronidazole  17    42.5 23  57.5 <0.001 
Metronidazole 
and Myrtus 
2    5 38  95 
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Discussion 
We concluded that 2% metronidazole 
vaginal gel plus Myrtus extract, 5 grams 
once daily for five consecutive nights, has 
a better efficacy in treatment of BV than 
metronidazole vaginal gel alone, without 
any dangerous complications. The 
remission rate five days after the beginning 
of the treatment was better in group of 
Myrtus (in metronidazole base) than group 
of metronidazole vaginal gel alone. 
Besides, the recurrence ratio was 30% in 
the metronidazole group which is 
consistent with the consequences of study 
of Sobel and colleagues (25.5%) (Alipour 
et al., 2014). 
Improvement was considered based on 
Amsel criteria, itching, burning, discharge, 
urinary frequency, disparonia, 
dysmenorrhea, age, occupation, education, 
and contraception method. In the 
readmission to track the effectiveness of 
treatment, presence or absence of Amsel 
criteria were considered as sign of 
remission (Sobel, 2000). 
Laboratory investigation demonstrated 
that among the plates having different 
dilutions of Myrtus extract, bacteria grew 
only at the dilution of 1.25 mg/ml and no 
bacteria grew at dilutions 2.5-20 mg/ml. 
So, MIC of Myrtus extract was considered 
2.5 mg/ml for bacterial vaginosis. Also, 
the amounts of phenols, flavonoids and 
flavonols of Myrtus extract were 91.08, 
62.70 and 34.38 mg/g, respectively. Using 
DPPH method, antioxidant activity of 
Myrtus extract was determined 
77.01μg/ml. This study is the first clinical 
trial assessing effect of metronidazole 
vaginal gel plus extract of Myrtus in the 
treatment of BV. Of course, several studies 
in vitro have demonstrated antimicrobial 
effects of Myrtus extract.  
Studies were performed on the chemical 
composition of Myrtus demonstrated that 
polyphenols, myrtucommulone, 
semimyrtucommulone, 1,8-cineole, α-
pinene, myrtenyl acetate, limonene, 
linalool and α-terpinolene are among the 
most important ingredients of Myrtus that 
have biological activities. This herb has 
been traditionally used to treat bacterial 
and fungal infections (Yadegarinia et al., 
2006; Houshmand et al., 2011). 
Furthermore, the study of Houshmand 
et al showed that extract of Myrtus had 
anti-bacterial effects at different 
concentrations on aerobic and anaerobic 
bacteria (Al-Saimary et al., 2002). AL- 
Saimary believed that the anti-bacterial 
activity of Myrtus is due to the increase of 
oxygen free radicals and lipid 
peroxidation, which can damage the cell 
wall of microorganisms (Hosseinzadeh et 
al., 2011). Also, analgesic and anti-
inflammatory effects of Myrtus have been 
demonstrated (Rossi et al., 2009). 
Therefore, therapeutic effects of Myrtus 
that have been reported by previous studies 
confirmed the results of the present study; 
so, Myrtus extract combined with 
metronidazole is more effective than 
metronidazole alone due to its anti-
bacterial, anti-inflammatory, and analgesic 
properties. Patients taking this 
combination in the follow-up period of 
three weeks after the end of treatment did 
not experience recurrence of infection, 
while patients in the metronidazole group 
encountered lower remission and a 
recurrence rate of 30%. 
Results of the study showed that the 
combination of metronidazole vaginal gel 
and Myrtus extract enhances the treatment 
efficiency of BV compared to 
metronidazole vaginal gel alone. We 
suggest more studies to be done for 
evaluating therapeutic effects of M. 
communis against other diseases.  
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